| Primary |
| Hereditary Angioedema |
17.1% |
| Idiopathic Thrombocytopenic Purpura |
14.3% |
| Angioedema |
10.0% |
| Gastrointestinal Angiodysplasia Haemorrhagic |
8.6% |
| Diffuse Large B-cell Lymphoma |
7.1% |
| Drug Use For Unknown Indication |
7.1% |
| Product Used For Unknown Indication |
7.1% |
| Hemolysis |
4.3% |
| Paroxysmal Nocturnal Haemoglobinuria |
4.3% |
| Pain |
2.9% |
| Premenstrual Syndrome |
2.9% |
| Thrombocytopenia |
2.9% |
| Anaemia Haemolytic Autoimmune |
1.4% |
| Angioneurotic Oedema |
1.4% |
| Aplastic Anaemia |
1.4% |
| Arthritis |
1.4% |
| Breast Pain |
1.4% |
| Chronic Hepatitis |
1.4% |
| Contraception |
1.4% |
| Diabetes Mellitus |
1.4% |
|
| Rhabdomyolysis |
14.3% |
| Hepatocellular Injury |
7.1% |
| Medication Error |
7.1% |
| Metrorrhagia |
7.1% |
| Pulmonary Fibrosis |
7.1% |
| Vomiting |
7.1% |
| Acne |
3.6% |
| Aggression |
3.6% |
| Blood Bilirubin Increased |
3.6% |
| Chronic Myeloid Leukaemia |
3.6% |
| Coronary Artery Occlusion |
3.6% |
| Drug Interaction |
3.6% |
| Fungal Skin Infection |
3.6% |
| Haemangioma |
3.6% |
| Hemiparesis |
3.6% |
| Hyponatraemia |
3.6% |
| Ischaemic Stroke |
3.6% |
| Loss Of Consciousness |
3.6% |
| Myalgia |
3.6% |
| Oedema |
3.6% |
|
| Secondary |
| Idiopathic Thrombocytopenic Purpura |
21.8% |
| Hereditary Angioedema |
18.5% |
| Drug Use For Unknown Indication |
11.6% |
| Product Used For Unknown Indication |
10.2% |
| Gastrointestinal Angiodysplasia Haemorrhagic |
6.5% |
| Immune Thrombocytopenic Purpura |
5.4% |
| Paroxysmal Nocturnal Haemoglobinuria |
3.5% |
| Prophylaxis |
3.2% |
| Antiphospholipid Syndrome |
2.7% |
| Hypertension |
2.2% |
| Aplastic Anaemia |
1.9% |
| Angioedema |
1.6% |
| Cytomegalovirus Infection |
1.6% |
| Eosinophilic Fasciitis |
1.6% |
| Immunosuppression |
1.6% |
| Angina Pectoris |
1.3% |
| Aplasia Pure Red Cell |
1.3% |
| B-cell Lymphoma |
1.3% |
| Convulsion |
1.1% |
| Coronary Artery Disease |
1.1% |
|
| Rhabdomyolysis |
14.5% |
| Weight Increased |
8.7% |
| Hereditary Angioedema |
7.2% |
| Liver Disorder |
7.2% |
| Metrorrhagia |
5.8% |
| Off Label Use |
5.8% |
| Thrombocytopenia |
5.8% |
| Vomiting |
5.8% |
| Drug Interaction |
4.3% |
| Thyroid Function Test Abnormal |
4.3% |
| White Blood Cell Count Increased |
4.3% |
| Back Pain |
2.9% |
| Hepatitis |
2.9% |
| Hepatitis Infectious Mononucleosis |
2.9% |
| Medication Error |
2.9% |
| Mood Swings |
2.9% |
| Myalgia |
2.9% |
| Pulmonary Embolism |
2.9% |
| Rash |
2.9% |
| Sjogren's Syndrome |
2.9% |
|
| Concomitant |
| Idiopathic Thrombocytopenic Purpura |
41.6% |
| Product Used For Unknown Indication |
15.8% |
| Hereditary Angioedema |
5.8% |
| Paroxysmal Nocturnal Haemoglobinuria |
4.7% |
| Aplastic Anaemia |
3.7% |
| Drug Use For Unknown Indication |
2.9% |
| Pain |
2.8% |
| Constipation |
2.7% |
| Prophylaxis |
2.6% |
| Thrombocytopenia |
2.3% |
| Hypertension |
2.1% |
| Asthma |
1.8% |
| Myelodysplastic Syndrome |
1.8% |
| Nausea |
1.8% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
| Premedication |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Insomnia |
1.3% |
| Hiv Test |
1.1% |
| Anaemia |
1.0% |
|
| Death |
15.2% |
| Drug Ineffective |
12.1% |
| Therapeutic Response Decreased |
11.1% |
| Thrombocytopenia |
7.4% |
| Platelet Count Decreased |
7.1% |
| Vomiting |
4.7% |
| Bone Marrow Reticulin Fibrosis |
4.4% |
| Anaemia |
3.7% |
| Weight Decreased |
3.7% |
| Hospitalisation |
3.4% |
| Liver Disorder |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Myelodysplastic Syndrome |
2.7% |
| Oedema Peripheral |
2.7% |
| Pyrexia |
2.7% |
| Rash |
2.7% |
| Vaginal Haemorrhage |
2.7% |
| Acute Myeloid Leukaemia |
2.4% |
| Red Blood Cell Schistocytes Present |
2.4% |
| Splenomegaly |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
20.9% |
| Drug Use For Unknown Indication |
18.6% |
| Hypertension |
9.3% |
| Idiopathic Thrombocytopenic Purpura |
9.3% |
| Hereditary Angioedema |
7.0% |
| Dyslipidaemia |
4.7% |
| Chronic Hepatitis |
2.3% |
| Contraception |
2.3% |
| Diabetes Mellitus |
2.3% |
| Embolism |
2.3% |
| Epilepsy |
2.3% |
| Hypercholesterolaemia |
2.3% |
| Hyperuricaemia |
2.3% |
| Insomnia |
2.3% |
| Iron Overload |
2.3% |
| Prophylaxis |
2.3% |
| Pulmonary Embolism |
2.3% |
| Renal Failure Chronic |
2.3% |
| Thrombocytopenia |
2.3% |
|
| Rhabdomyolysis |
66.7% |
| Drug Interaction |
8.3% |
| Renal Failure Acute |
8.3% |
| Serum Ferritin Increased |
8.3% |
| Vomiting |
8.3% |
|
